Certified Adviser

Novakand Pharma’s financial instrument has been traded on the First North Premier Growth Market up until April 13 2026 and the company has appointed Redeye North Growth AB as Certified Adviser. In its role as Certified Adviser, Redeye Nordic Growth AB has monitored the company’s compliance with the Nasdaq First North Growth Market rules.

The company is currently not listed on a stock exchange or other approved marketplace and therefore is not required to have a Certified Adviser appointed.